These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
210 related articles for article (PubMed ID: 24993502)
1. Evaluation of the need of elective implantable cardioverter-defibrillator generator replacement in primary prevention patients without prior appropriate ICD therapy. Yap SC; Schaer BA; Bhagwandien RE; Kühne M; Dabiri Abkenari L; Osswald S; Szili-Torok T; Sticherling C; Theuns DA Heart; 2014 Aug; 100(15):1188-92. PubMed ID: 24993502 [TBL] [Abstract][Full Text] [Related]
2. Death without prior appropriate implantable cardioverter-defibrillator therapy: a competing risk study. Koller MT; Schaer B; Wolbers M; Sticherling C; Bucher HC; Osswald S Circulation; 2008 Apr; 117(15):1918-26. PubMed ID: 18391108 [TBL] [Abstract][Full Text] [Related]
3. Clinical prediction model for death prior to appropriate therapy in primary prevention implantable cardioverter defibrillator patients with ischaemic heart disease: the FADES risk score. van Rees JB; Borleffs CJ; van Welsenes GH; van der Velde ET; Bax JJ; van Erven L; Putter H; van der Bom JG; Schalij MJ Heart; 2012 Jun; 98(11):872-7. PubMed ID: 22581736 [TBL] [Abstract][Full Text] [Related]
4. Primary prevention implantable cardioverter defibrillator recipients: the need for defibrillator back-up after an event-free first battery service-life. Van Welsenes GH; Van Rees JB; Thijssen J; Trines SA; Van Erven L; Schalij MJ; Borleffs CJ J Cardiovasc Electrophysiol; 2011 Dec; 22(12):1346-50. PubMed ID: 21777328 [TBL] [Abstract][Full Text] [Related]
8. Appropriate therapies predict long-term mortality in primary and secondary prevention of sudden cardiac death. Stabile G; D'Agostino C; Gallo P; Marrazzo N; Iuliano A; De Simone A; Turco P; Palella M; Donnici G; Ciardiello C; Napolitano G; Solimene F J Cardiovasc Med (Hagerstown); 2013 Feb; 14(2):110-3. PubMed ID: 22367567 [TBL] [Abstract][Full Text] [Related]
9. Incidence and predictors of implantable cardioverter-defibrillator therapy in patients with arrhythmogenic right ventricular dysplasia/cardiomyopathy undergoing implantable cardioverter-defibrillator implantation for primary prevention. Bhonsale A; James CA; Tichnell C; Murray B; Gagarin D; Philips B; Dalal D; Tedford R; Russell SD; Abraham T; Tandri H; Judge DP; Calkins H J Am Coll Cardiol; 2011 Sep; 58(14):1485-96. PubMed ID: 21939834 [TBL] [Abstract][Full Text] [Related]
10. Time dependence of risks and benefits in pediatric primary prevention implantable cardioverter-defibrillator therapy. DeWitt ES; Triedman JK; Cecchin F; Mah DY; Abrams DJ; Walsh EP; Gauvreau K; Alexander ME Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1057-63. PubMed ID: 25262116 [TBL] [Abstract][Full Text] [Related]
11. [The implantable cardioverter-defibrillator and hypertrophic cardiomyopathy. Experience at three centers]. Marín F; Gimeno JR; Payá E; García-Alberola A; Pérez-Alvarez L; Fernández X; de la Morena G; Sogorb F; Castro-Beiras A; Valdés M; Martínez JG; Monserrat L Rev Esp Cardiol; 2006 Jun; 59(6):537-44. PubMed ID: 16790196 [TBL] [Abstract][Full Text] [Related]
12. Incidence of appropriate implantable cardioverter-defibrillator therapy and mortality after implantable cardioverter-defibrillator generator replacement: results from a real-world nationwide cohort. Ruwald MH; Ruwald AC; Johansen JB; Gislason G; Nielsen JC; Philbert B; Riahi S; Vinther M; Lindhardt TB Europace; 2019 Aug; 21(8):1211-1219. PubMed ID: 31329849 [TBL] [Abstract][Full Text] [Related]
13. Ventricular arrhythmias among implantable cardioverter-defibrillator recipients for primary prevention: impact of chronic total coronary occlusion (VACTO Primary Study). Nombela-Franco L; Mitroi CD; Fernández-Lozano I; García-Touchard A; Toquero J; Castro-Urda V; Fernández-Diaz JA; Perez-Pereira E; Beltrán-Correas P; Segovia J; Werner GS; Javier G; Luis AP Circ Arrhythm Electrophysiol; 2012 Feb; 5(1):147-54. PubMed ID: 22205684 [TBL] [Abstract][Full Text] [Related]
14. Use of primary prevention implantable cardioverter-defibrillators in a population-based cohort is associated with a significant survival benefit. Parkash R; Sapp JL; Basta M; Doucette S; Thompson K; Gardner M; Gray C; Brownell B; Kidwai H; Cox J Circ Arrhythm Electrophysiol; 2012 Aug; 5(4):706-13. PubMed ID: 22685111 [TBL] [Abstract][Full Text] [Related]
15. The Occurrence of Implantable Cardioverter Defibrillator Therapies After Generator Replacement in Patients Who No Longer Meet Primary Prevention Indications. Kawata H; Hirai T; Doukas D; Hirai R; Steinbrunner J; Wilson J; Noda T; Hsu J; Krummen D; Feld G; Wilber D; Santucci P; Birgersdotter-Green U J Cardiovasc Electrophysiol; 2016 Jun; 27(6):724-9. PubMed ID: 26915696 [TBL] [Abstract][Full Text] [Related]
16. Determinants of patient survival rate after implantation of a cardioverter-defibrillator without resynchronisation capability. Lelakowski J; Piekarz J; Rydlewska A; Majewski J; Senderek T; Ząbek A; Małecka B Kardiol Pol; 2012; 70(11):1099-110. PubMed ID: 23180517 [TBL] [Abstract][Full Text] [Related]
17. Predictors of appropriate implantable cardioverter defibrillator (ICD) therapy in primary prevention patients with ischemic and nonischemic cardiomyopathy. Verma A; Sarak B; Kaplan AJ; Oosthuizen R; Beardsall M; Wulffhart Z; Higenbottam J; Khaykin Y Pacing Clin Electrophysiol; 2010 Mar; 33(3):320-9. PubMed ID: 19796352 [TBL] [Abstract][Full Text] [Related]
18. The ICD for primary prevention in patients with inherited cardiac diseases: indications, use, and outcome: a comparison with secondary prevention. Olde Nordkamp LR; Wilde AA; Tijssen JG; Knops RE; van Dessel PF; de Groot JR Circ Arrhythm Electrophysiol; 2013 Feb; 6(1):91-100. PubMed ID: 23275262 [TBL] [Abstract][Full Text] [Related]
19. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults. Chatrath R; Porter CB; Ackerman MJ Mayo Clin Proc; 2002 Mar; 77(3):226-31. PubMed ID: 11888025 [TBL] [Abstract][Full Text] [Related]
20. Indication to cardioverter-defibrillator therapy and outcome in real world primary prevention. Data from the IRIDE [Italian registry of prophylactic implantation of defibrillators] study. Proclemer A; Muser D; Campana A; Zoni-Berisso M; Zecchin M; Locatelli A; Brieda M; Gramegna L; Santarone M; Chiodi L; Mazzone P; Rebellato L; Facchin D Int J Cardiol; 2013 Sep; 168(2):1416-21. PubMed ID: 23287697 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]